Proteolytic enzyme and adiponectin receptors as potential targets for COVID-19 therapy

by K. A. Rubina, N. R. Sabitova, A. Yu. Efimenko, N. I. Kalinina, J. A. Akopyan, E. V. Semina
Published 2021-05-01

The unique invasiveness of glioblastoma and possible drug targets on extracellular matrix

by Hatoum A, Mohammed R, Zakieh O
Published 2019-02-01

Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillation

by Noboru Ichihara, Masatoshi Miyamura, Daichi Maeda, Tomohiro Fujisaka, Shu-ichi Fujita, Hideaki Morita, Yoshihiro Takeda, Takahide Ito, Koichi Sohmiya, Masaaki Hoshiga, Nobukazu Ishizaka
Published 2017-10-01

Lipids isolated from bone induce the migration of human breast cancer cells

by Jeane Silva, Somsankar Dasgupta, Guanghu Wang, Kannan Krishnamurthy, Edmond Ritter, Erhard Bieberich
Published 2006-04-01

The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study

by Ruizhao Li, Zhiyong Xie, Li Zhang, Ying Huang, Jianchao Ma, Wei Dong, Zhilian Li, Yuanhan Chen, Huaban Liang, Yanhua Wu, Xingchen Zhao, Wenjian Wang, Zhiming Ye, Shuangxin Liu, Wei Shi, Xinling Liang
Published 2021-01-01

Fibrinolysis protease receptors promote activation of astrocytes to express pro-inflammatory cytokines

by Paola Pontecorvi, Michael A. Banki, Carlotta Zampieri, Cristina Zalfa, Pardis Azmoon, Maria Z. Kounnas, Cinzia Marchese, Steven L. Gonias, Elisabetta Mantuano
Published 2019-12-01

Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies

by Burcin Özdirik, Anna Stueven, Jana Knorr, Lukas Geisler, Raphael Mohr, Münevver Demir, Teresa Hellberg, Sven H. Loosen, Fabian Benz, Bertram Wiedenmann, Frank Tacke, Alexander Wree, Henning Jann, Christoph Roderburg
Published 2020-05-01

Soluble urokinase-type plasminogen activator receptor as a biomarker of treatment response in childhood tuberculosis

by Ery Olivianto, Sri Sudarwati, Heda Melinda Nataprawira
Published 2019-01-01

Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis

by Yumeng Wen, Sapna Shah, Kirk N. Campbell
Published 2018-04-01

Circulating Soluble Urokinase-Type Plasminogen Activator Receptor Levels Reflect Renal Function in Newly Diagnosed Patients with Multiple Myeloma Treated with Bortezomib-Based Indu...

by Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Gerasimos-Petros Papassotiriou, Efstathios Kastritis, Alexandra Margeli, Nikolaos Kanellias, Evangelos Eleutherakis-Papaiakovou, Magdalini Migkou, Despina Fotiou, Maria Roussou, Maria Gavriatopoulou, Panagiotis Malandrakis, Erasmia Psimenou, Ioannis Papassotiriou, Meletios A. Dimopoulos
Published 2020-10-01

Aspirin Inhibits IKK-β-mediated Prostate Cancer Cell Invasion by Targeting Matrix Metalloproteinase-9 and Urokinase-Type Plasminogen Activator

by Chongjun Shi, Nini Zhang, Yang Feng, Jiewei Cao, Xuyi Chen, Bin Liu
Published 2017-03-01

Advances on the components of fibrinolytic system in malignant tumors

by Zengzheng Ge, Xiaoyan Xu, Zengyu Ge, Shaopeng Zhou, Xiulin Li, Kai Yao, Lan Deng
Published 2019-01-01

The effect of anti-human plasminogen monoclonal antibodies on Glu-plasminogen activation by plasminogen activators

by M. Akrami, M. Mirshahi, K. Khajeh, H. Naderimanesh
Published 2006-07-01

Development of AE147 Peptide-Conjugated Nanocarriers for Targeting uPAR-Overexpressing Cancer Cells

by Park JY, Shin Y, Won WR, Lim C, Kim JC, Kang K, Husni P, Lee ES, Youn YS, Oh KT
Published 2021-08-01

Plasminogen Activators in Neurovascular and Neurodegenerative Disorders

by Manuel Yepes, Yena Woo, Cynthia Martin-Jimenez
Published 2021-04-01

uPAR PET/CT for Prognostication and Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer Undergoing Radium-223 Therapy: A Prospective Phase II Study

by Marie Øbro Fosbøl, Jann Mortensen, Peter Meidahl Petersen, Annika Loft, Jacob Madsen, Andreas Kjaer
Published 2021-06-01

CRISPR/Cas9 uPAR Gene Knockout Results in Tumor Growth Inhibition, EGFR Downregulation and Induction of Stemness Markers in Melanoma and Colon Carcinoma Cell Lines

by Alessio Biagioni, Anastasia Chillà, Mario Del Rosso, Gabriella Fibbi, Francesca Scavone, Elena Andreucci, Silvia Peppicelli, Francesca Bianchini, Lido Calorini, Anna Li Santi, Pia Ragno, Francesca Margheri, Anna Laurenzana
Published 2021-05-01

The diagnostic value of soluble urokinase-type plasminogen activator receptor (suPAR) for the discrimination of vertebral osteomyelitis and degenerative diseases of the spine

by Jan Simon Scharrenberg, Ayla Yagdiran, Julia Brinkmann, Maik Brune, Jan Siewe, Norma Jung, Esther Mahabir
Published 2019-11-01

The Predictive Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention

by Qin Y, Qiao Y, Wang D, Yan G, Tang C, Ma G
Published 2021-10-01

Predictive value of plasma soluble urokinase-type plasminogen activator receptor for post-severe traumatic multiple organ dysfunction syndrome

by ZHAO Yinjie, LI Yang, SHEN Yajing, GUI Yongqing, ZHANG Jun, ZHANG Yuansong, LIU Minghua, XIANG Qiang
Published 2021-04-01